603351.SH
Nanjing Well Pharmaceutical Co., Ltd.
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 27.45
+5.54%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 24.63x
- PEG TTM
- 3.12x
- Price / book
- 2.08x
- Price / sales
- 2.69x
- Price / cash flow
- 15.47x
Enterprise value
- Enterprise value
- CNY 3.7B
- EV / sales
- 2.79x
- EV / EBITDA
- 12.62x
- EV / EBIT
- 21.52x
- Market cap
- CNY 3.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026